NASDAQ · Analyst Forecast

Bone Biologics Corp (BBLG) Stock Forecast & Price Target

$0.31 NASDAQ: BBLG Market Cap $1.05M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 15, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Bone Biologics Corp (BBLG), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Bone Biologics Corp, the average estimate for 2027 earnings per share is −$0.59; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2024$0$0$01
2025$0$0$01
2026$0$0$01
2027$0$0$01

Earnings per share forecast

YearLowAverageHighAnalysts
2024−$19.02−$19.02−$19.021
2025−$2.36−$2.36−$2.361
2026−$1.18−$1.18−$1.181
2027−$0.59−$0.59−$0.591

Bone Biologics Corp (BBLG) forecast — frequently asked questions

What are analysts forecasting for Bone Biologics Corp's earnings?

The average analyst estimate for Bone Biologics Corp (BBLG) earnings per share in 2027 is -0.59, with individual estimates between -0.59 and -0.59.

How much revenue is Bone Biologics Corp expected to make?

Analysts forecast Bone Biologics Corp (BBLG) revenue of $0 in 2027, based on 1 published estimates.

How many analysts cover BBLG?

1 analyst contribute estimates for Bone Biologics Corp (BBLG). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Devices stocks

ABT forecastISRG forecastMDT forecastSYK forecastBSX forecastEW forecastRMD forecastDXCM forecastPHG forecastZBH forecastAll Medical - Devices stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.